Select Page
Researchers from the University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) have discovered a unique nano-scaled DNA signature that appears to be common to all cancers. Based on this discovery, the team has developed a novel technology that enables cancer to be quickly and easily detected from any tissue type, e.g. blood or biopsy. The study, which was supported by a grant from the National Breast Cancer Foundation and is published in the journal Nature Communications, reveals new insight about how epigenetic reprogramming in cancer regulates the physical and chemical properties of DNA and could lead to an entirely new approach to point-of-care diagnostics.